 Sushil Kumar
Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helicobacter pylori | 4 | 2010 | 44 | 0.970 |
Why?
| | Neoplastic Stem Cells | 2 | 2014 | 409 | 0.630 |
Why?
| | Antigens, Bacterial | 2 | 2010 | 126 | 0.550 |
Why?
| | Grape Seed Extract | 2 | 2014 | 29 | 0.530 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2014 | 178 | 0.480 |
Why?
| | Helicobacter Infections | 3 | 2010 | 30 | 0.450 |
Why?
| | Genetic Variation | 2 | 2010 | 977 | 0.430 |
Why?
| | Glutathione Transferase | 2 | 2011 | 92 | 0.430 |
Why?
| | Aldehydes | 2 | 2011 | 140 | 0.410 |
Why?
| | Spheroids, Cellular | 1 | 2014 | 74 | 0.400 |
Why?
| | Interleukin-4 | 1 | 2014 | 207 | 0.390 |
Why?
| | Silymarin | 1 | 2014 | 147 | 0.380 |
Why?
| | Adipocytes | 1 | 2014 | 223 | 0.380 |
Why?
| | Bacterial Proteins | 2 | 2010 | 968 | 0.360 |
Why?
| | Carcinogens, Environmental | 1 | 2011 | 14 | 0.350 |
Why?
| | Polymerase Chain Reaction | 3 | 2010 | 1043 | 0.350 |
Why?
| | GTPase-Activating Proteins | 1 | 2011 | 81 | 0.340 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2011 | 117 | 0.330 |
Why?
| | Acetylcysteine | 1 | 2011 | 139 | 0.330 |
Why?
| | Interleukin-6 | 1 | 2014 | 780 | 0.310 |
Why?
| | Colorectal Neoplasms | 2 | 2014 | 868 | 0.300 |
Why?
| | Stomach | 1 | 2008 | 111 | 0.270 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2009 | 253 | 0.270 |
Why?
| | Stomach Neoplasms | 1 | 2009 | 128 | 0.260 |
Why?
| | Interleukin-1beta | 1 | 2009 | 390 | 0.250 |
Why?
| | Cell Proliferation | 1 | 2014 | 2514 | 0.240 |
Why?
| | HT29 Cells | 2 | 2014 | 37 | 0.210 |
Why?
| | India | 2 | 2010 | 213 | 0.140 |
Why?
| | Phylogeny | 2 | 2010 | 917 | 0.120 |
Why?
| | Neoplasms | 1 | 2011 | 2913 | 0.120 |
Why?
| | HCT116 Cells | 1 | 2014 | 76 | 0.110 |
Why?
| | Kinetics | 2 | 2014 | 1568 | 0.100 |
Why?
| | Signal Transduction | 4 | 2014 | 5226 | 0.100 |
Why?
| | Microscopy, Confocal | 1 | 2014 | 319 | 0.100 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 118 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 979 | 0.090 |
Why?
| | Colonic Neoplasms | 1 | 2014 | 258 | 0.090 |
Why?
| | DNA, Bacterial | 2 | 2010 | 320 | 0.090 |
Why?
| | Xenobiotics | 1 | 2011 | 30 | 0.090 |
Why?
| | Retinal Pigment Epithelium | 1 | 2011 | 79 | 0.080 |
Why?
| | Chemoprevention | 1 | 2011 | 92 | 0.080 |
Why?
| | Neoplasm Transplantation | 1 | 2011 | 246 | 0.080 |
Why?
| | Cell Survival | 1 | 2014 | 1105 | 0.080 |
Why?
| | Remission Induction | 1 | 2011 | 306 | 0.080 |
Why?
| | Metabolic Networks and Pathways | 1 | 2011 | 175 | 0.080 |
Why?
| | Neoplasm Proteins | 1 | 2014 | 442 | 0.080 |
Why?
| | Antioxidants | 1 | 2014 | 550 | 0.080 |
Why?
| | Genes, Bacterial | 1 | 2010 | 152 | 0.080 |
Why?
| | Bacteria, Aerobic | 1 | 2009 | 7 | 0.080 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2010 | 60 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2028 | 0.080 |
Why?
| | Bacterial Typing Techniques | 1 | 2009 | 40 | 0.080 |
Why?
| | Mice, Nude | 1 | 2011 | 680 | 0.080 |
Why?
| | Diabetic Foot | 1 | 2009 | 25 | 0.070 |
Why?
| | DNA Primers | 1 | 2010 | 505 | 0.070 |
Why?
| | Virulence | 1 | 2010 | 278 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2014 | 584 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 3551 | 0.070 |
Why?
| | Species Specificity | 1 | 2010 | 546 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 552 | 0.070 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2010 | 508 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 1450 | 0.070 |
Why?
| | Bacterial Infections | 1 | 2009 | 247 | 0.060 |
Why?
| | Base Sequence | 1 | 2010 | 2171 | 0.060 |
Why?
| | Risk | 1 | 2009 | 923 | 0.060 |
Why?
| | Polymorphism, Genetic | 1 | 2009 | 615 | 0.060 |
Why?
| | Models, Biological | 1 | 2014 | 1764 | 0.060 |
Why?
| | Transcription Factors | 1 | 2014 | 1736 | 0.060 |
Why?
| | Apoptosis | 1 | 2014 | 2445 | 0.060 |
Why?
| | Humans | 9 | 2014 | 145785 | 0.060 |
Why?
| | Mice | 2 | 2014 | 18358 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2883 | 0.060 |
Why?
| | Biopsy | 1 | 2008 | 1082 | 0.050 |
Why?
| | Oxidative Stress | 1 | 2011 | 1361 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 2000 | 0.050 |
Why?
| | Genotype | 1 | 2008 | 1857 | 0.050 |
Why?
| | Animals | 2 | 2014 | 38106 | 0.040 |
Why?
| | Aged | 3 | 2009 | 26217 | 0.040 |
Why?
| | Middle Aged | 3 | 2009 | 36309 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2008 | 8347 | 0.030 |
Why?
| | Male | 4 | 2011 | 73012 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2014 | 25 | 0.030 |
Why?
| | Peptide Mapping | 1 | 2014 | 62 | 0.030 |
Why?
| | Protein Stability | 1 | 2014 | 176 | 0.020 |
Why?
| | Methionine | 1 | 2014 | 161 | 0.020 |
Why?
| | Female | 3 | 2009 | 79045 | 0.020 |
Why?
| | Hormesis | 1 | 2011 | 2 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2011 | 112 | 0.020 |
Why?
| | Down-Regulation | 1 | 2014 | 618 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2014 | 473 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 1069 | 0.020 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2009 | 117 | 0.020 |
Why?
| | Wound Healing | 1 | 2011 | 355 | 0.020 |
Why?
| | Adolescent | 1 | 2008 | 22577 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2009 | 365 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2014 | 935 | 0.020 |
Why?
| | Cell Movement | 1 | 2011 | 963 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 1188 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2823 | 0.010 |
Why?
| | Adult | 1 | 2008 | 40882 | 0.010 |
Why?
|
|
Kumar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|